▶ 調査レポート

膵内分泌腫瘍薬の世界市場レポート2020

• 英文タイトル:Global Pancreatic Endocrine Tumor Drug Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。膵内分泌腫瘍薬の世界市場レポート2020 / Global Pancreatic Endocrine Tumor Drug Sales Market Report 2020 / 20QY06-08770資料のイメージです。• レポートコード:20QY06-08770
• 出版社/出版日:QYResearch / 2020年6月1日
• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥420,000 (USD4,000)▷ お問い合わせ
  Multi User¥630,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥840,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、膵内分泌腫瘍薬のグローバル市場について種類別(塩酸ブパリシブ、乳酸ドビチニブ、フォスブレタブリントロメタミン、酢酸ランレオチド、MPHE-001B、その他)、用途別(クリニック、研究センター、病院)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・膵内分泌腫瘍薬市場の概要
・世界の主要地域別膵内分泌腫瘍薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の膵内分泌腫瘍薬市場規模2015-2026:種類別(塩酸ブパリシブ、乳酸ドビチニブ、フォスブレタブリントロメタミン、酢酸ランレオチド、MPHE-001B、その他)
・世界の膵内分泌腫瘍薬市場規模2015-2026:用途別(クリニック、研究センター、病院)
・膵内分泌腫瘍薬の北米市場規模2015-2020
・膵内分泌腫瘍薬のヨーロッパ市場規模2015-2020
・膵内分泌腫瘍薬の中国市場規模2015-2020
・膵内分泌腫瘍薬の日本市場規模2015-2020
・膵内分泌腫瘍薬の東南アジア市場規模2015-2020
・膵内分泌腫瘍薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Ipsen S.A.、Jiangsu Hengrui Medicine Co., Ltd.、MediaPharma s.r.l.、Novartis AG、OXiGENE, Inc.)
・膵内分泌腫瘍薬の製造コスト分析
・販売チャネル、流通業者、顧客
・膵内分泌腫瘍薬の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Pancreatic Endocrine Tumor Drug Market
The global Pancreatic Endocrine Tumor Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Pancreatic Endocrine Tumor Drug Scope and Market Size
The global Pancreatic Endocrine Tumor Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Endocrine Tumor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Pancreatic Endocrine Tumor Drug market is segmented into
Buparlisib Hydrochloride
Dovitinib Lactate
Fosbretabulin Tromethamine
Lanreotide Acetate
MPHE-001B
Others

Segment by Application, the Pancreatic Endocrine Tumor Drug market is segmented into
Clinic
Research Center
Hospital
The Pancreatic Endocrine Tumor Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Pancreatic Endocrine Tumor Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pancreatic Endocrine Tumor Drug Market Share Analysis
Pancreatic Endocrine Tumor Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pancreatic Endocrine Tumor Drug business, the date to enter into the Pancreatic Endocrine Tumor Drug market, Pancreatic Endocrine Tumor Drug product introduction, recent developments, etc.
The major vendors covered:
Ipsen S.A.
Jiangsu Hengrui Medicine Co., Ltd.
MediaPharma s.r.l.
Novartis AG
OXiGENE, Inc.

レポート目次

Table of Contents

1 Pancreatic Endocrine Tumor Drug Market Overview
1.1 Pancreatic Endocrine Tumor Drug Product Scope
1.2 Pancreatic Endocrine Tumor Drug Segment by Type
1.2.1 Global Pancreatic Endocrine Tumor Drug Sales by Type (2020-2026)
1.2.2 Buparlisib Hydrochloride
1.2.3 Dovitinib Lactate
1.2.4 Fosbretabulin Tromethamine
1.2.5 Lanreotide Acetate
1.2.6 MPHE-001B
1.2.7 Others
1.3 Pancreatic Endocrine Tumor Drug Segment by Application
1.3.1 Global Pancreatic Endocrine Tumor Drug Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.4 Pancreatic Endocrine Tumor Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pancreatic Endocrine Tumor Drug Sales Growth Rate (2015-2026)
1.4.2 Global Pancreatic Endocrine Tumor Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Pancreatic Endocrine Tumor Drug Price Trends (2015-2026)

2 Pancreatic Endocrine Tumor Drug Estimate and Forecast by Region
2.1 Global Pancreatic Endocrine Tumor Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pancreatic Endocrine Tumor Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region (2015-2020)
2.3 Global Pancreatic Endocrine Tumor Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pancreatic Endocrine Tumor Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pancreatic Endocrine Tumor Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
2.4.2 Europe Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
2.4.3 China Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
2.4.4 Japan Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
2.4.6 India Pancreatic Endocrine Tumor Drug Estimates and Projections (2015-2026)
3 Global Pancreatic Endocrine Tumor Drug Competition Landscape by Players
3.1 Global Top Pancreatic Endocrine Tumor Drug Players by Sales (2015-2020)
3.2 Global Top Pancreatic Endocrine Tumor Drug Players by Revenue (2015-2020)
3.3 Global Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Endocrine Tumor Drug as of 2019)
3.4 Global Pancreatic Endocrine Tumor Drug Average Price by Company (2015-2020)
3.5 Manufacturers Pancreatic Endocrine Tumor Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pancreatic Endocrine Tumor Drug Players (Opinion Leaders)
4 Global Pancreatic Endocrine Tumor Drug Market Size by Type
4.1 Global Pancreatic Endocrine Tumor Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Pancreatic Endocrine Tumor Drug Price by Type (2014-2020)
4.2 Global Pancreatic Endocrine Tumor Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pancreatic Endocrine Tumor Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pancreatic Endocrine Tumor Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Pancreatic Endocrine Tumor Drug Price Forecast by Type (2021-2026)
5 Global Pancreatic Endocrine Tumor Drug Market Size by Application
5.1 Global Pancreatic Endocrine Tumor Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Pancreatic Endocrine Tumor Drug Price by Application (2015-2020)
5.2 Global Pancreatic Endocrine Tumor Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pancreatic Endocrine Tumor Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pancreatic Endocrine Tumor Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pancreatic Endocrine Tumor Drug Price Forecast by Application (2021-2026)

3 North America Pancreatic Endocrine Tumor Drug Market Facts & Figures
3.2 North America Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
3.3 North America Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
3.4 North America Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

4 Europe Pancreatic Endocrine Tumor Drug Market Facts & Figures
4.2 Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
4.3 Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
4.4 Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

5 China Pancreatic Endocrine Tumor Drug Market Facts & Figures
5.2 China Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
5.3 China Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
5.4 China Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

6 Japan Pancreatic Endocrine Tumor Drug Market Facts & Figures
6.2 Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
6.3 Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
6.4 Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Pancreatic Endocrine Tumor Drug Market Facts & Figures
7.2 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

8 India Pancreatic Endocrine Tumor Drug Market Facts & Figures
8.2 India Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
8.3 India Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
8.4 India Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Pancreatic Endocrine Tumor Drug Business
12.1 Ipsen S.A.
12.1.1 Ipsen S.A. Pancreatic Endocrine Tumor Drug Corporation Information
12.1.2 Ipsen S.A. Pancreatic Endocrine Tumor Drug Business Overview and Total Revenue
12.1.3 Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ipsen S.A. Pancreatic Endocrine Tumor Drug Products Offered
12.1.5 Ipsen S.A. Recent Development
12.2 Jiangsu Hengrui Medicine Co., Ltd.
12.2.1 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Corporation Information
12.2.2 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Business Overview and Total Revenue
12.2.3 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Products Offered
12.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
12.3 MediaPharma s.r.l.
12.3.1 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Corporation Information
12.3.2 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Business Overview and Total Revenue
12.3.3 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Products Offered
12.3.5 MediaPharma s.r.l. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Pancreatic Endocrine Tumor Drug Corporation Information
12.4.2 Novartis AG Pancreatic Endocrine Tumor Drug Business Overview and Total Revenue
12.4.3 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG Pancreatic Endocrine Tumor Drug Products Offered
12.4.5 Novartis AG Recent Development
12.5 OXiGENE, Inc.
12.5.1 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Corporation Information
12.5.2 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Business Overview and Total Revenue
12.5.3 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Products Offered
12.5.5 OXiGENE, Inc. Recent Development

13 Pancreatic Endocrine Tumor Drug Manufacturing Cost Analysis
13.1 Pancreatic Endocrine Tumor Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
13.4 Pancreatic Endocrine Tumor Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pancreatic Endocrine Tumor Drug Distributors List
14.3 Pancreatic Endocrine Tumor Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Pancreatic Endocrine Tumor Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Region (2015-2020)
Table 6. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pancreatic Endocrine Tumor Drug Revenue Share by Region (2015-2020)
Table 8. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Pancreatic Endocrine Tumor Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pancreatic Endocrine Tumor Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pancreatic Endocrine Tumor Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Pancreatic Endocrine Tumor Drug Sales Share by Company (2015-2020)
Table 14. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pancreatic Endocrine Tumor Drug Revenue Share by Company (2015-2020)
Table 16. Global Pancreatic Endocrine Tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Endocrine Tumor Drug as of 2019)
Table 17. Global Pancreatic Endocrine Tumor Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Pancreatic Endocrine Tumor Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Pancreatic Endocrine Tumor Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pancreatic Endocrine Tumor Drug Players
Table 22. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Pancreatic Endocrine Tumor Drug Sales Share by Type (2015-2020)
Table 24. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pancreatic Endocrine Tumor Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Pancreatic Endocrine Tumor Drug Sales Share by Type (2021-2026)
Table 27. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pancreatic Endocrine Tumor Drug Revenue Share by Type (2021-2026)
Table 29. Global Pancreatic Endocrine Tumor Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Pancreatic Endocrine Tumor Drug Sales Share by Application (2015-2020)
Table 32. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pancreatic Endocrine Tumor Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Pancreatic Endocrine Tumor Drug Sales Share by Application (2021-2026)
Table 36. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pancreatic Endocrine Tumor Drug Revenue Share by Application (2021-2026)
Table 38. Global Pancreatic Endocrine Tumor Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 41. United States Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 43. United States Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 51. China Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 53. China Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 55. China Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
Table 69. India Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Pancreatic Endocrine Tumor Drug Sales Market Share by Company (2015-2020)
Table 71. India Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Pancreatic Endocrine Tumor Drug Sales Market Share by Type (2015-2020)
Table 73. India Pancreatic Endocrine Tumor Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Pancreatic Endocrine Tumor Drug Sales Market Share by Application (2015-2020)
Table 75. Ipsen S.A. Corporation Information
Table 76. Ipsen S.A. Description and Business Overview
Table 77. Ipsen S.A. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Ipsen S.A. Pancreatic Endocrine Tumor Drug Product
Table 79. Ipsen S.A. Recent Development
Table 80. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
Table 81. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Jiangsu Hengrui Medicine Co., Ltd. Pancreatic Endocrine Tumor Drug Product
Table 84. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
Table 85. MediaPharma s.r.l. Corporation Information
Table 86. MediaPharma s.r.l. Description and Business Overview
Table 87. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. MediaPharma s.r.l. Pancreatic Endocrine Tumor Drug Product
Table 89. MediaPharma s.r.l. Recent Development
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Novartis AG Pancreatic Endocrine Tumor Drug Product
Table 94. Novartis AG Recent Development
Table 95. OXiGENE, Inc. Corporation Information
Table 96. OXiGENE, Inc. Description and Business Overview
Table 97. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. OXiGENE, Inc. Pancreatic Endocrine Tumor Drug Product
Table 99. OXiGENE, Inc. Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Pancreatic Endocrine Tumor Drug Distributors List
Table 103. Pancreatic Endocrine Tumor Drug Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Pancreatic Endocrine Tumor Drug Product Picture
Figure 2. Global Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pancreatic Endocrine Tumor Drug Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Research Center Examples
Figure 8. Hospital Examples
Figure 9. Global Pancreatic Endocrine Tumor Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Pancreatic Endocrine Tumor Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pancreatic Endocrine Tumor Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pancreatic Endocrine Tumor Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pancreatic Endocrine Tumor Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pancreatic Endocrine Tumor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pancreatic Endocrine Tumor Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pancreatic Endocrine Tumor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pancreatic Endocrine Tumor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pancreatic Endocrine Tumor Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pancreatic Endocrine Tumor Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pancreatic Endocrine Tumor Drug Players Market Share by Revenue in Pancreatic Endocrine Tumor Drug 2015 & 2019
Figure 27. Pancreatic Endocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pancreatic Endocrine Tumor Drug Revenue Share by Type (2015-2020)
Figure 29. Global Pancreatic Endocrine Tumor Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pancreatic Endocrine Tumor Drug Revenue Share by Application (2015-2020)
Figure 31. Global Pancreatic Endocrine Tumor Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 33. United States Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 34. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Company in 2019
Figure 35. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 36. Europe Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2019
Figure 37. China Pancreatic Endocrine Tumor Drug Sales Market Share by Company in 2019
Figure 38. China Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 39. China Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2019
Figure 40. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Company in 2019
Figure 41. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 42. Japan Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2019
Figure 46. India Pancreatic Endocrine Tumor Drug Sales Market Share by Company in 2019
Figure 47. India Pancreatic Endocrine Tumor Drug Sales Market Share by Type in 2019
Figure 48. India Pancreatic Endocrine Tumor Drug Sales Market Share by Application in 2019
Figure 49. Ipsen S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Jiangsu Hengrui Medicine Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. MediaPharma s.r.l. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. OXiGENE, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Pancreatic Endocrine Tumor Drug
Figure 56. Manufacturing Process Analysis of Pancreatic Endocrine Tumor Drug
Figure 57. Pancreatic Endocrine Tumor Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed